COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

COVID symptoms, testing, shielding impact on patient‐reported outcomes and early vaccine responses in individuals with multiple myeloma

Published:2021-08-02 Issue:1 Volume:196 Page:95-98
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ramasamy Karthik¹²^ORCID,Sadler Ross¹,Jeans Sally³,Varghese Sherin¹,Turner Alison²,Larham Jemma¹,Gray Nathanael²,Barrett Joe²,Bowcock Stella⁴^ORCID,Cook Gordon⁵^ORCID,Kyriakou Chara⁶,Smith Dean⁷,Drayson Mark⁸,Basu Supratik⁹¹⁰,Moore Sally¹¹¹,McDonald Sarah¹²,Gooding Sarah²,Javaid Muhammad K.²

Affiliation:

1. Oxford University Hospitals NHS Trust Oxford UK

2. Oxford University Oxford UK

3. RUDY Study Participant Forum Member OxfordUK

4. King’s College Hospital NHS Trust LondonUK

5. Leeds Institute of Clinical Trials Research University of Leeds LeedsUK

6. University College London Hospitals NHS Trust LondonUK

7. Nottingham University Hospitals NHS Trust NottinghamUK

8. University of Birmingham BirminghamUK

9. University of Wolverhampton Wolverhampton UK

10. Royal Wolverhampton NHS Trust WolverhamptonUK

11. Bath Royal United Hospitals BathUK

12. Myeloma UK Edinburgh UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17764

Reference10 articles.

1. Real‐world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID‐19 disease) in patients with multiple myeloma receiving systemic anti‐cancer therapy

2. Myeloma clinical outcomes following the first wave of COVID‐19: results from the Thames Valley Cancer Alliance (UK)

3. Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management

4. The RUDY study platform – a novel approach to patient driven research in rare musculoskeletal diseases

5. The Hospital Anxiety and Depression Scale

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Examining the immunological responses to COVID-19 vaccination in multiple myeloma patients: a systematic review and meta-analysis;BMC Geriatrics;2024-05-08

2. Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma;Haematologica;2024-01-25

3. Determinants of durable humoral and T cell immunity in myeloma patients following COVID‐19 vaccination;European Journal of Haematology;2023-12-20

4. Mental health and life satisfaction among those advised to shield during the COVID-19 pandemic in the UK: a secondary analysis of the Understanding Society longitudinal study;Frontiers in Public Health;2023-09-27

5. Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma;Frontiers in Oncology;2023-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3